EGFR and non-small cell lung carcinoma: A significant proportion of non-small cell lung cancers (NSCLCs) carry epidermal growth factor receptor (EGFR) gene mutations [2–6], which have been identified in approximately 10–30% of NSCLCs [7, 8].